GlassScriptPhysician profile
Jonathan T Foster
NPI 1538262605
$7,566.80
in general payments reported to CMS, 2019-2025
34 companies · $776 in 2025
The $776 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,259 · 2020: $944 · 2021: $1,289 · 2022: $1,095 · 2023: $1,075 · 2024: $1,129 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,863 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,863.36 |
| Education | $116.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,709.29 | 2019-2024 | |
| Astellas Pharma US INC | $741.31 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $585.18 | 2021-2025 | |
| Exeltis, USA INC. | $492.55 | 2019-2025 | Slynd |
| Pfizer INC. | $415.49 | 2019-2024 | |
| Exact Sciences Corporation | $381.27 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $365.78 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $288.47 | 2023-2025 | Myfembree, Gemtesa |
| Lupin INC. | $284.64 | 2019-2021 | |
| Agile Therapeutics, INC. | $219.63 | 2021-2024 | Twirla |
| Millicent US INC | $205.72 | 2019-2025 | Femlyv, Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $205.24 | 2019-2025 | |
| Myovant Sciences INC. | $167.79 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $160.19 | 2021 | |
| Merck Sharp & Dohme LLC | $140.95 | 2019-2024 | Gardasil 9, Gardasil |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $139.14 | 2019 | |
| Organon LLC | $131.50 | 2021-2025 | Nexplanon |
| Aspira Women'S Health INC | $126.34 | 2021-2024 | Ova1 |
| Avion Pharmaceuticals | $110.73 | 2019-2020 | |
| Sage Therapeutics, LLC | $104.79 | 2024-2025 | Zurzuvae |
| Medicem INC. | $92.69 | 2021-2022 | |
| Allergan, INC. | $70.97 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $66.50 | 2019-2021 | |
| Medtronic Vascular, INC. | $64.39 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $46.30 | 2019-2020 | |
| Duchesnay USA Incorporated | $45.69 | 2019 | |
| Evofem Biosciences, INC. | $39.98 | 2021-2022 | |
| Coopersurgical, INC. | $39.53 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $33.54 | 2019 | |
| Amgen INC. | $23.69 | 2023 | Prolia, Evenity |
| Scynexis, INC. | $18.21 | 2022 | |
| Mission Pharmacal Company | $17.90 | 2019 | |
| Avanos Medical | $16.78 | 2019 | |
| Shield Therapeutics INC | $14.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.